EC Microbiology

Review Article Volume 18 Issue 12 - 2022

Radiographic Findings of Respiratory Diseases

Baraa Faiez Rajab1*, Ayman Ali Alhabeeb2, Ameen Abdullah Hayyan3, Hamza Raed Wazzan4, Alaa Ahmed Abutaleb5, Rawan Mohammed Alanazi6, Sarah Abdo Saif7, Waleed Khallufah Saad8, Asma Awadh Alharthi9, Moayad Khalid Ahmed10, Mohammed Majed Abualshamat11, Abdulmalik Hassan Alsabban11, Abdulrhman Taj Uddin M Alsawas11 and Ghazy Radhy Al Hamad12

1King Abdulaziz Hospital, Jeddah, Saudi Arabia

2Aljafer General Hospital, Alhasa, Saudi Arabia

3Safwa General Hospital, Qatif, Saudi Arabia

4Al-Noor Specialist Hospital, Makkah, Saudi Arabia

5Prince Mohammed Bin Naser Hospital, Jazan, Saudi Arabia

6King Fahad Hospital, Jeddah, Saudi Arabia

7Bugshan Hospital, Jeddah, Saudi Arabia

8Alsawda Primary Health Care, Abha, Saudi Arabia

9King Abdullah Medical City, Makkah, Saudi Arabia

10King Saud University, Riyadh, Saudi Arabia

11Herra General Hospital, Makkah, Saudi Arabia

12King Fahad Hospital, Hofuf, Saudi Arabia

*Corresponding Author: Baraa Faiez Rajab, Consultant General Medicine, King Abdulaziz Hospital, Jeddah, Saudi Arabia.
Received: November 22, 2022; Published: November 22, 2022

Introduction: In order to diagnose and monitor respiratory illnesses, imaging is crucial. The care of patients and the identification of prognostic variables can be aided by chest radiography, bedside lung ultrasonography, and computed tomography scans are other imaging modalities. Because imaging results are not always specific, it is important to consider a number of potential differential diagnoses. There have only been a few large-scale, controlled comparison trials using various radiological procedures. Initiating a diagnostic examination with a chest X-ray gives a broad orientation and is particularly helpful for detecting pneumonia, malignancy, and chronic obstructive pulmonary disease (COPD). At a far lower radiation dose than before-only 0.2 - 5 mSv-multidetector CT provides almost isotropic spatial resolution. The primary indications for it, according to current recommendations, are tumors, acute pulmonary embolism, pulmonary hypertension, pulmonary fibrosis, severe COPD, and pneumonia in a high-risk patient. The diagnosis of pulmonary embolism, bronchial cancer, pulmonary hypertension, and cystic fibrosis is made using magnetic resonance imaging (MRI).

Aim of the Study: This review article will present both established and suggested radiological techniques as well as recently developed techniques used in the treatment of the most significant lung diseases, highlighting their benefits and drawbacks, frequency of use, financial information, and radiation doses involved.

Methodology: Comprehensive research of radiographic findings of respiratory diseases. PUBMED search engine was the mainly used database for the search process, articles collected from the year 2001 to 2021. The term used in the search were: Chest x-ray, MRI, CT imaging, emphysema, asthma, pleural effusion, tuberculosis, aspiration fibrosis, pneumonia.

Conclusion: It is important to provide appropriate treatment without overusing diagnostic tests; the choice of radiological technology for the detection, staging, follow-up and quantification of lung illness should be based on specific clinical alternatives.


Keywords: Chest X-Ray; MRI; CT Imaging; Emphysema; Asthma; Pleural Effusion; Tuberculosis; Aspiration Fibrosis; Pneumonia

  1. Mathers CD and Loncar D. “Projections of global mortality and burden of disease from 2002 to 2030”. PLoS Medicine11 (2006): e442.
  2. Raoof S., et al. “Interpretation of plain chest roentgenogram”. Chest2 (2012): 545-558.
  3. Kido S., et al. “Detection and classification of lung abnormalities by use of convolutional neural network (CNN) and regions with CNN features (R-CNN)”. In 2018 International workshop on advanced image technology (IWAIT) IEEE (2018): 1-4.
  4. Zompatori M., et al. “Overview of current lung imaging in acute respiratory distress syndrome”. European Respiratory Review134 (2014): 519-530.
  5. Souid A., et al. “Classification and predictions of lung diseases from chest x-rays using mobilenet v2”. Applied Sciences6 (2021): 2751.
  6. Stark P. High resolution computed tomography of the lungs (2007).
  7. Wielpütz M and Kauczor HU. “MRI of the lung: state of the art”. Diagnostic and Interventional Radiology4 (2012): 344.
  8. Franquet T. “Imaging of pneumonia: trends and algorithms”. European Respiratory Journal1 (2001): 196-208.
  9. Self WH., et al. “High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia”. The American Journal of Emergency Medicine2 (2013): 401-405.
  10. Wielpütz MO., et al. “Radiological diagnosis in lung disease: factoring treatment options into the choice of diagnostic modality”. Deutsches Ärzteblatt International11 (2014): 181.
  11. Hollings N and Shaw P. “Diagnostic imaging of lung cancer”. European Respiratory Journal4 (2002): 722-742.
  12. Hochhegger B., et al. “MRI in lung cancer: a pictorial essay”. The British Journal of Radiology1003 (2011): 661-668.
  13. Schellhaaß A., et al. “The diagnosis and treatment of acute pulmonary embolism”. Deutsches Ärzteblatt International34-35 (2010): 589.
  14. Gibson RL., et al. “Pathophysiology and management of pulmonary infections in cystic fibrosis”. American Journal of Respiratory and Critical Care Medicine8 (2003): 918-951.
  15. Wielpütz MO., et al. “Magnetic resonance imaging of cystic fibrosis lung disease”. Journal of Thoracic Imaging3 (2013): 151-159.
  16. Arakawa A., et al. “Assessment of lung volumes in pulmonary emphysema using multidetector helical CT: comparison with pulmonary function tests”. Computerized Medical Imaging and Graphics5 (2001): 399-404.
  17. Raghu G., et al. “An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management”. American Journal of Respiratory and Critical Care Medicine6 (2011): 788-824.

Baraa Faiez Rajab., et al. “Radiographic Findings of Respiratory Diseases”. EC Microbiology  18.12 (2022): 43-50.